Clinical Trial Using Pupillometry to Measure Nociception in Healthy Volunteers.
NCT ID: NCT04864340
Last Updated: 2021-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2021-04-30
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study in healthy volunteers aims to evaluate whether the PDR can be a reliable and discriminatory measure of the intensity of nociception, applying various types of nociceptive stimuli. If so, this study could lead to the use of pupillometry as an objective measure of nociception in settings where patients cannot communicate, such as intensive care areas or perioperative settings.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability of Pupil Response to Acute Pain
NCT02628314
Effect of Ventilation Mode in the Pupillary Light Reflex: A Crossover Study
NCT07082569
Characteristics of the Vergence Responses of Binocularly Normal Subjects After a Vision Therapy Protocol
NCT05208658
Pupillometry Use & Professional's Inspection : Leveling Subjectivity
NCT06733207
Effect of Different Color Lights on the Internal Clock and Alertness in Humans
NCT05423002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
threshold stimulation (tetanic)
CE marked medical device
Tetanic stimulation
upper threshold stimulation (tetanic)
CE marked medical device
Tetanic stimulation
threshold stimulation (pressure)
Algometer
Pressure stimulation
upper threshold stimulation (pressure)
Algometer
Pressure stimulation
non nociceptive procedure (fine touch)
Comparator
Non-nociceptive procedure (fine touch)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CE marked medical device
Tetanic stimulation
Algometer
Pressure stimulation
Comparator
Non-nociceptive procedure (fine touch)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Caucasian race
3. Ages between 25 and 65 years old (balanced, 50% from 25-45 and 50% from 45-65)
4. Body weight within the normal range (Quetelet index: 19-30)
5. Clinical history, physical examination and vital signs within normality
6. Free acceptance to participate, with written informed consent
Exclusion Criteria
2. Significant consumption of stimulating drinks (\> 5 coffees, teas, chocolate or cola drinks / day).
3. Taking any medication in the 15 days prior to the study and / or medicinal plants that may have an effect on the pupil (beta-blockers, droperidol, metoclopramide, clonidine ...). Oral contraceptives and paracetamol will be allowed.
4. Pregnancy (β-hCG test).
5. Menstruation and / or dysmenorrhea on the day of the study
6. Family or personal history or clinical evidence of psychiatric, neurological or ophthalmological problems: anxiety, depression, Parkinson's, glaucoma, dry eyes, retinal diseases, eye surgery and pupil abnormalities, presenting migraine pathology and diabetes
7. Pupillary diameter ≥ 5mm
8. Smokers or ex-smokers \<6 months.
9. Have participated in a clinical trial in the 3 months prior to the start of this study.
25 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIBSP-PUP-2019-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.